Lv, Z., Wei, Y., Chen, F., Xu, W. (2026). CCL3
                    <sup>+</sup>
                    neutrophil signature as a predictor of response to neoadjuvant toripalimab plus chemotherapy in hypopharyngeal squamous cell carcinoma: A phase II trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6116